Skip to content
10-K

Annual Report

Orion Biotech Opportunities Corp.

0001213900-23-024075

← back to feed
Filed
Mar 29, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow FY 2022 · Dec 31, 2022 −$376.76K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$1.22M
Cash And Equivalents FY 2022 · Dec 31, 2022 $265.72K
Cash And Equivalents FY 2022 · Dec 31, 2021 $712.47K
Stockholders Equity FY 2022 · Dec 31, 2022 −$7.79M
Stockholders Equity FY 2022 · Dec 31, 2021 −$13.76M
Current Liabilities FY 2022 · Dec 31, 2022 $67.59K
Current Liabilities FY 2022 · Dec 31, 2021 $81.63K
Total Liabilities FY 2022 · Dec 31, 2022 $8.33M
Total Liabilities FY 2022 · Dec 31, 2021 $15.12M
Current Assets FY 2022 · Dec 31, 2022 $439.32K
Current Assets FY 2022 · Dec 31, 2021 $1.35M
Total Assets FY 2022 · Dec 31, 2022 $203.33M
Total Assets FY 2022 · Dec 31, 2021 $201.36M
Sga Expense FY 2022 · Dec 31, 2022 $779.67K
Sga Expense FY 2022 · Dec 31, 2021 $553.69K
Net Income FY 2022 · Dec 31, 2022 $8.76M
Net Income FY 2022 · Dec 31, 2021 −$724.5K
Operating Income FY 2022 · Dec 31, 2022 −$899.67K
Operating Income FY 2022 · Dec 31, 2021 −$628.21K